QA: Coeptis Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001819663_2022_Coeptis_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001819663, Coeptis Therapeutics Inc

  xvar xval
0 AssetsCurrent 2,179,558
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,926
3 remainder_Assets 4,572,092
4 LiabilitiesCurrent 2,764,942
5 LiabilitiesNoncurrent 1,650,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,118,014
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 190,052
11 remainder_Revenues 75,000
12 remainder_NetIncome 783,786
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 6,765,576
1 Liabilities 4,414,942
2 Expenses 14,308,066
3 Revenues 75,000
4 StockholdersEquity 2,350,634
5 NetIncome -13,449,280
6 ComprehensiveNetIncome -13,449,280
7 BaseVar 13,173,685
8 EconomicCapitalRatiobeforeLimitedLiability -1.49
9 EconomicCapitalRatio 1.18

Edgar->Model Mapping

Feature Distribution